Stay updated with breaking news from Nasdaq Amph. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Amphastar Pharmaceuticals (NASDAQ:AMPH – Get Rating) will be issuing its quarterly earnings data after the market closes on Monday, May 9th. Analysts expect the company to announce earnings of $0.33 per share for the quarter. Amphastar Pharmaceuticals (NASDAQ:AMPH – Get Rating) last released its quarterly earnings data on Thursday, March 10th. The company reported $0.42 […]
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Get Rating) Director Floyd F. Petersen sold 295 shares of the stock in a transaction that occurred on Monday, May 2nd. The stock was sold at an average price of $35.18, for a total transaction of $10,378.10. Following the completion of the sale, the director now owns 76,078 shares in […]
Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Get Rating) have received an average rating of “Hold” from the six analysts that are covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and two have given a buy rating to the company. The […]
Amphastar Pharmaceuticals (NASDAQ:AMPH – Get Rating) had its price objective boosted by research analysts at Northland Securities from $33.00 to $43.00 in a research note issued to investors on Monday, The Fly reports. Northland Securities’ price target would indicate a potential upside of 4.47% from the company’s current price. A number of other brokerages have […]
Assenagon Asset Management S.A. raised its stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Get Rating) by 196.8% during the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 527,678 shares of the company’s stock after buying an additional 349,875 shares during the quarter. Assenagon Asset Management S.A.’s holdings in Amphastar […]